代表作 |
1. Zhao Q, Guo J, Wang G, Bi Y, Cheng X, Liao Y, Jin S, Li L, Guo Y, Pan L, Zhang X, Tan Y, Zhou G *, Yu X *. CXCL13 promotes intestinal tumorigenesis through the activation of epithelial AKT signaling. Cancer Letters. 2021 Apr 21; 511:1-14. （通讯作者；影响因子8.679，医学1区，Top期刊） 2. Qun Zhao #, Xianjun Yu #, Ming Li, Yongbo Liu, Yamei Han, Xixi Zhang, Xiaoming Li, Xiaoxia Wu, Jun Qin, Jing Fang, Haibing Zhang *. MLKL attenuates colon inflammation and colitis-tumorigenesis via suppression of inflammatory responses.Cancer Letters. 2019;459:100-111.（共同第一作者；影响因子8.679，医学1区，Top期刊） 3. Qun Zhao #, Yun Bi #, Jing Zhong, Xiang Li, Jian Guo, Ying-xiang Liu, Long-rui Pan, Yan Tan, Zhang-shuang Deng *, Xian-jun Yu *. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation. Acta Pharmacologica Sinica. 2021, 42(5), 791–800.（通讯作者，影响因子6.1，医学1区，Top期刊，中国科技期刊卓越行动计划重点期刊）。 4. Qun Zhao , Yun Bi, Jian Guo, Yingxiang Liu, Jing Zhong, Longrui Pan, Yan Tan, Xianjun Yu *. Pristimerin protects against inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Acta Pharmacologica Sinica. 2021, 42(6), 975–986.（通讯作者，影响因子6.1，医学1区，Top期刊，中国科技期刊卓越行动计划重点期刊） 5. Qun Zhao#, *, Jian Guo #, Xinran Cheng, Yingying Liao, Yun Bi, Yingxia Gong, Xudong Zhang, Yang Guo, Xianhui Wang, Wei Yu, Shu Jin, Yan Tan and Xianjun Yu* RIPK3 suppresses the progression of spontaneous intestinal tumorigenesis. 2021, Frontiers in oncology, 11, 664927.（通讯作者，影响因子6.244，医学2区） 6. Qun Zhao#, Xinran Cheng#, Wei Yu#, Yun Bi, Jian Guo, Qingzhao Ma, Yingxia Gong, Li He*, Xianjun Yu*. Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway. Phytomedicine; 2021 Nov;92:153723 (通讯作者；影响因子5,34；医学1区，TOP 期刊) 7. Qun Zhao # , Jing Zhong #, Yun Bi, Yongqiang Liu, Yingxiang Liu, Jian Guo, Longrui Pan, Yan Tan, Xianjun Yu *. Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK. Phytomedicine. 2020;78:153306.（通讯作者，影响因子5.34，医学1区，Top期刊） 8. Qun Zhao #, Yun Bi #, Jian Guo, Yingxiang Liu, Jing Zhong, Yongqiang Liu, Longrui Pan, Yang Guo, Yan Tan, Xianjun Yu *. Effect of pristimerin on apoptosis through activation of ROS/endoplasmic reticulum (ER) stress-mediated Noxa in colorectal cancer. Phytomedicine. 2021;80:153399.（通讯作者，影响因子5.34，医学1区，Top期刊） 9. Qun Zhao *, Xinran Cheng, Jian Guo, Yun Bi, Li Kuang, Jianhua Ren, Jing Zhong, Longrui Pan, Xudong Zhang, Yang Guo, Yongqiang Liu, Shu Jin, Yan Tan, Xianjun Yu *. MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway. International Journal of Biological Sciences. 2021; 17(3): 869-881.（通讯作者，影响因子6.58，生物科学2区） 10. Qun Zhao #, Yingxiang Liu #, Jing Zhong, Yun Bi, Yongqiang Liu, Ziting Ren, Xiang Li, Junjun Jia, Mengting Yu, Xianjun Yu *. Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo. Cell Death Discovery. 2019; 5: 125.（通讯作者，影响因子5.241，医学2区） 11. Qun Zhao, Yun Bi, Jing Zhong, Ziting Ren, Yingxiang Liu, Junjun Jia, Mengting Yu, Yan Tan, Qiufang Zhang, Xianjun Yu *. Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt/β-catenin signaling. Toxicology and applied pharmacology. 2020;386:114813.（通讯作者，影响因子4.219，医学2区） 12. Xianjun Yu#, Minjun Yang #, Bo Zhou #, Guizhen Wang #, Yunchao Huang #, Lichuan Wu #, Xin Cheng, Zhesheng Wen, Jinyan Huang, Yundong Zhang, Xiaohong Gao, Gaofeng Li, Shuiwang He, Zhaohui Gu, Liang Ma, Chunming Pan, Ping Wang, Haobin Chen, Zhipeng Hong, Xiaolu Wang, Wenjing Mao, Xiaolong Jin, Hui Kang, Shuting Chen, Yongqiang Zhu, Wenyi Gu, Zi Liu, Hui Dong, Linwei Tian, Saijuan Chen*, Yi Cao*, Shengyue Wang*, Guangbiao Zhou*. Characterization of somatic mutations in air pollution-related lung cancer. EBioMedicine. 2015 Apr 7;2(6):583-90. (Evaluated by Faculty of 1000 Biology). (共同第一作者，影响因子8.143，医学1区). |
